Search results
Results from the WOW.Com Content Network
The following are settlements reached with US authorities against pharmaceutical companies to resolve allegations of "off-label" promotion of drugs. Under the Federal Food, Drug, and Cosmetic Act, it is illegal for pharmaceutical companies to promote their products for uses not approved by the Food and Drug Administration (FDA), and corporations that market drugs for off-label indications may ...
Metformin was approved in Canada in 1972, [6] but did not receive approval by the U.S. Food and Drug Administration (FDA) for type 2 diabetes until 1994. [170] Produced under license by Bristol-Myers Squibb , Glucophage was the first branded formulation of metformin to be marketed in the U.S., beginning on 3 March 1995. [ 171 ]
The VICP was adopted in response to concerns over the pertussis portion of the DPT vaccine. [1] Several U.S. lawsuits against vaccine makers won substantial awards. Most makers ceased production, and the last remaining major manufacturer threatened to do so. [1] The VICP uses a no-fault system for resolving vaccine injury claims. [1]
The Republican president's nominee is “financially vested in finding fault with vaccines,” Cassidy, the chairman of the health committee, noted as he ended Thursday's confirmation hearing. Kennedy also stopped short of making other commitments, refusing to promise that he would not engage in lobbying Health and Human Services after his term ...
Robert F. Kennedy Jr.'s personal attorney previously petitioned the Food and Drug Administration to revoke its approval of a polio vaccine, highlighting an influential Kennedy ally who, sources ...
The lawsuits come about two weeks after Novo Nordisk filed similar claims against U.S. medical spas and wellness clinics. Wegovy is approved for weight loss, while the other two drugs are approved ...
In a decision on Friday, the 9th U.S. Circuit Court of Appeals in Pasadena, California, said the nonprofit did not show that Meta worked with or was coerced by federal officials to suppress views ...
Empagliflozin/metformin was approved for use in the European Union in May 2015. [6] Empagliflozin/metformin was approved for use in the United States in August 2015. [7] [12] The extended release version was approved for use in the United States in December 2016. [13] [14] Empagliflozin/metformin was approved for use in Australia in May 2020. [2]